# Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

> **NCT01069367** · PHASE4 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 100 (actual)

## Conditions studied

- Swine-Origin Influenza A H1N1 Virus

## Interventions

- **BIOLOGICAL:** Emulsion, Cell Culture-based, influenza HA vaccine H1N1

## Key facts

- **NCT ID:** NCT01069367
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069367, "Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01069367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*